Prana Biotechnology Limited (PBT)

Prana Biotechnology is a biotechnology company focused on the research and development of treatments for Alzheimer's Disease and other major neurodegenerative disorders.

Location:
Melbourne, Australia
Market Cap:
$26 million
No. Shares:
533,891,470
Sector:
Health Care
Website:
www.pranabio.com
Share Price & Volume

 

 

 

 

 

 

 

 

AusBiotech Member

AusBiotech Member

DISCLAIMER: Orient Capital Pty Ltd has taken all reasonable care in publishing the information contained in this Open Briefing®; furthermore, the entirety of this Open Briefing® has been approved for release to the market by the participating company. It is information given in a summary form and does not purport to be complete. The information contained is not intended to be used as the basis for making any investment decision and you are solely responsible for any use you choose to make of the information. We strongly advise that you seek independent professional advice before making any investment decisions. Orient Capital Pty Ltd is not responsible for any consequences of the use you make of the information, including any loss or damage you or a third party might suffer as a result of that use.

Latest Market Announcements

Load next 5 items

ASX Announcements delayed by 20 minutes.